Average Royalty Rate for Licensing Intellectual Property

Sooner or later somebody asks you for a number. A licensee, a board, a co-founder, a lawyer drafting a term sheet. So you look up the average royalty rate for licensing intellectual property, and the answer arrives quickly and confidently: four to six percent of net sales, higher in software, lower in automotive, ranging from 0.1 percent to 25 percent depending on the invention.

That number is real. What it describes is the problem.

The short answer, with the caveats attached

Two datasets sit underneath almost everything published on this question.

The first is the Licensing Executives Society royalty survey. In its 2021 high tech round, the average royalty rate was 4.82 percent and the median 4.75 percent, with the average across the four surveys since 2011 at 5.66 percent and the median holding steady at 5 percent.

The second is Robert Goldscheider's study of the RoyaltySource database, which analysed 1,533 licences involving running royalties on sales across fifteen industries, and found an all-industry median of 4.5 percent with industry medians running from 2.8 percent to 8.0 percent. Those licences were signed between the late 1980s and 2000.

So four to five percent is a fair central tendency, and anyone quoting you something in that band is not making it up. The caveat belongs in the same breath: these are the rates in deals that were signed, disclosed, and survey-eligible. They describe a population your patent may not belong to.

Where the industry averages come from

The paywalled version of this data is sold as an annual benchmark study covering 14 industries and over 30 years of transactions, reported with averages, medians and interquartile ranges. The free pages ranking for this query are, almost without exception, summaries of summaries of it. That is why they agree with each other so neatly, and why none of them show you the spread.

The spread is the interesting part. From the Goldscheider sample:

Healthcare products has a median of 4.8 percent and a range of 0.1 to 77 percent. A distribution that wide is not a price list. Quoting its midpoint as your rate is like pricing a house from the national average, in a country with both palaces and sheds.

If you want the sector-by-sector view rather than the mechanism, that belongs in a separate piece on royalty rates by industry.

Why the average is higher than what one patent gets

Here is the finding that changes what you should ask for, and it appears on none of the pages currently ranking for this term.

In the combined LES samples, deals in which patents were the only intellectual property licensed averaged 3.77 percent. Deals bundling multiple types of IP averaged 6.28 percent. Aerospace technology carried the highest average of any technology type at 10.7 percent, according to the same survey analysis.

Read that gap carefully. The headline average is pulled upward by transactions where the patent travelled with something else: know-how, drawings, designs, trade secrets, engineering support, sometimes people. The licensee in those deals is not buying a right to exclude. They are buying the ability to actually build the thing, and they are paying for the whole package.

If what you hold is a patent family and nothing else, the relevant benchmark is closer to 3.77 percent than to the headline. That is not a discount you are being talked into. It is a different product.

Development stage compounds the same effect. Only about a third of the deals in the 2021 survey involved technology at a fully developed or in-production stage, while 67 percent of the high tech deals sat at R&D, invention disclosure or prototype stage, and advanced-stage technology commands a materially higher rate. Early rights price like early rights. A pending application prices below an issued one for the same reason a foundation prices below a house.

The rate is only half the number

A royalty is a rate multiplied by a base. The industry says "four percent" and stops, which is roughly as useful as an exchange rate with no currencies named.

The arithmetic is unforgiving and worth internalising: a 10 dollar royalty on a 1,000 dollar product can be obtained by applying 1 percent to a 1,000 dollar base or 10 percent to a 100 dollar base. Same money, rates differing by a factor of ten. Any comparison of two rates sitting on two different bases is noise.

Which base is defensible is not a matter of taste. Where a patented feature sits inside a multi-component product, the royalty base should not be larger than the smallest salable unit embodying the patented invention, and the combination of base and rate must reflect the value attributable to the infringing features and no more. Your invention improves the sensor, not the vehicle. The base is the sensor.

Practically, that means the base is the first thing to settle in a negotiation, not the last. A sophisticated licensee knows this and will happily concede a headline rate that sounds generous once they have quietly won the argument about what it multiplies.

What actually moves your rate

Three things, in descending order of how often they are ignored.

The licensee's margin sets the ceiling

A royalty is paid out of the licensee's profit, so their cost structure caps what is payable before either side opens their mouth. The framework courts use makes this explicit: Georgia-Pacific factor 12 asks what portion of profit is customarily allowed for use of an invention in that business, which ties rates directly to sector margins. Software at roughly 80 percent gross margin can sustain 5 to 15 percent, while automotive at roughly 12.5 percent cannot absorb much above 3 to 5 percent, which is why telecom standard-essential patents use per-unit caps such as Qualcomm's 3.25 percent of device price capped at 400 dollars, or Avanci's 20 dollars per 4G vehicle and 32 dollars per 5G vehicle.

If you are licensing into a thin-margin industry, a per-unit figure will usually get you further than a percentage. Argue the mechanism, not the number.

Exclusivity, field of use, and where the money sits

Exclusivity is priced, and the survey work quantifies exclusivity and advanced-stage premiums directly rather than leaving them to instinct. Upfront money trades against the running rate as well: take more at signature and the percentage comes down, take less and it goes up, because the licensee is pricing your willingness to share their risk.

Field of use is the most under-used lever an owner has. One patent family can support several non-competing licences carved by industry, territory or application. At EX-IX we structure rights sales and licences exactly this way, carved by industry, territory or field of use with title kept whole. Three narrow licences at four percent frequently beat one broad licence at six, and they leave the asset intact.

Whether anyone can tell you are being infringed

This is the one that decides whether a rate is money or decoration. A running royalty is a promise to pay based on facts the licensee reports about their own sales. If use of your invention is invisible from outside the factory, you have an audit clause and a hope.

Detectability is therefore a pricing input, not a legal afterthought. It is why we run a validation gate before a patent reaches any buyer, reconstructing the claims and testing detectability and validity probability, benchmarked at 0.76 percent mean absolute percentage error against real-world outcomes. An owner who can demonstrate that infringement is observable is negotiating from a different position than one who cannot, and the rate follows.

Do not build your ask on the 25 percent rule

You will meet the 25 percent rule quickly: the licensor takes a quarter of the licensee's expected profit on the product. The Goldscheider data lent it some support, putting the median royalty at 26.7 percent of licensee operating profit margin.

Treat it as arithmetic, not authority. In 2011 the US Federal Circuit rejected it in Uniloc v Microsoft as a fundamentally flawed tool for determining a baseline royalty rate, and the underlying empirical case is thin: over 80 percent of the royalty rates in the database were essentially bare numbers with no description of the intellectual property licensed, frequently bundling patents with copyrights or entire portfolios.

As a sanity check on affordability it is fine. If a proposed rate would consume most of the licensee's margin, the deal will not survive contact with their finance team. As a justification for your number in front of a counterparty who knows the case law, it is a liability.

How to set your number

Work in this order.

Define the base first, and write it into the term sheet before any percentage appears. Find comparables in the same shape as your deal, meaning a single patent family, the same exclusivity, the same development stage, rather than any licence that happens to share your industry label. Position against the licensee's margin, because that is the constraint that actually binds. Decide your split between upfront and running money as a deliberate risk trade. And know your detectability position before the first call, because it determines whether you are pricing an asset or an argument.

One last thing worth saying plainly. Licensing is not always the right answer. If the annual renewal fees are outrunning any realistic royalty stream, or the buyer set is small enough that one transaction ends the matter, selling it outright is often the cleaner outcome. Either way the groundwork is the same, and it starts with honest patent valuation methods rather than a table of industry averages.

FAQ

What is a typical royalty rate for a patent?

Around 4 to 5 percent of net sales is the usual central tendency across published surveys. For a single patent family licensed with no know-how attached, the more honest benchmark is nearer 3.77 percent, and individual industry bands stretch from a fraction of a percent to well into double digits.

Is a royalty a percentage of profit or of sales?

Almost always sales, applied to an apportioned base rather than the whole product. Profit-based splits come from the 25 percent rule, which US courts have rejected as a baseline method, though the licensee's profit margin still sets the practical ceiling.

Why do some licences pay per unit instead of a percentage?

Because thin-margin, multi-component products cannot absorb a percentage of the whole device price. Major standard-essential patent holders publish per-unit figures and caps for exactly this reason.

Does a lump sum beat a running royalty?

It removes collection risk, audit friction and the chance that the licensee quietly deprioritises the product. It also caps your upside. Treat it as a risk trade rather than a value trade, and price the certainty accordingly.

Can I license a patent application that has not issued yet?

Yes, and it is common: most surveyed deals sit at pre-grant stages. Expect it to price lower, since advanced-stage technology carries a measurable premium, and expect the licensee to want terms that adjust if the claims narrow during examination.